refractory anemia
Showing 1 - 21 of 21
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,
Active, not recruiting
- Acute Biphenotypic Leukemia
- +18 more
- Cyclophosphamide
- +8 more
-
Aurora, Colorado
- +2 more
Dec 28, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)
Recruiting
- Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 20, 2022
Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in
Completed
- Acute Myeloid Leukemia
- +5 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2021
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020
Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia
Completed
- Adult Acute Myeloid Leukemia in Remission
- +29 more
- Fludarabine Phosphate
- +5 more
-
Tucson, Arizona
- +9 more
Dec 18, 2019
AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)
Completed
- AML
- +11 more
-
Boston, MassachusettsBoston Children's Hospital
Oct 31, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +19 more
- umbilical cord blood transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019
Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)
Completed
- Chronic Myelomonocytic Leukemia
- +7 more
- flow cytometry
- +7 more
-
Cleveland, Ohio
- +1 more
Feb 21, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +117 more
- vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Jun 28, 2018
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally
Completed
- Adult Acute Lymphoblastic Leukemia in Remission
- +27 more
-
Baltimore, MarylandJohns Hopkins University
Jun 16, 2017
de Novo Fanconi Anemia in Younger Newly Diagnosed Acute Myeloid
Completed
- Childhood Acute Erythroleukemia (M6)
- +17 more
- laboratory biomarker analysis
-
Monrovia, CaliforniaChildren's Oncology Group
May 13, 2016
Childhood MDS, de Novo MDS, Previously Treated MDS Trial in Arcadia (lenalidomide)
Completed
- Childhood Myelodysplastic Syndromes
- +8 more
-
Arcadia, CaliforniaCOG Phase I Consortium
Jun 10, 2014
Chronic Myelomonocytic Leukemia, de Novo MDS, Previously Treated MDS Trial in Houston (tipifarnib, laboratory biomarker
Completed
- Chronic Myelomonocytic Leukemia
- +7 more
- tipifarnib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2013
Chronic Myelomonocytic Leukemia, de Novo MDS, Previously Treated MDS Trial in Rochester (thalidomide, laboratory biomarker
Completed
- Chronic Myelomonocytic Leukemia
- +7 more
- thalidomide
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Jan 23, 2013
Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a)
Completed
- Childhood Acute Erythroleukemia (M6)
- +15 more
- asparaginase
- +15 more
-
Arcadia, CaliforniaChildren's Oncology Group
Jan 15, 2013
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +17 more
- bryostatin 1
- +3 more
-
Baltimore, MarylandJohns Hopkins University
Jan 8, 2013
Small Bowel Disease, Gastrointestinal Hemorrhage, Refractory Anemia Trial in London (Senna, Citramag powder, Metoclopramide)
Unknown status
- Small Bowel Disease
- +2 more
- Senna
- +2 more
-
London, United KingdomSt Mark's Hospital, North West London Hospitals NHS Trust
Sep 21, 2007